Riskpilot← Back to searchSign inGet full accessLÆGEHUSET KERTEMINDE ApS
APSActiveCVR 14313192Vestre Stationsvej 25General medical practice activities · NACE 8621Est. 19903 employees
Revenue 2025
DKK 1,2M
-31% vs 2024
EBITDA margin
62.9%
-34% vs 2024
Equity ratio
57.2%
Financial strength
Net profit 2025
DKK 502K
-37% vs 2024
| Revenue | DKK 1,2M | -31% |
| EBITDA | DKK 731K | -34% |
| Net profit | DKK 502K | -37% |
| Total assets | DKK 8M | +0% |
| Equity | DKK 4,6M | +7% |
| Employees | 3 | — |
Legal name
LÆGEHUSET KERTEMINDE ApS
CVR number
14313192
Legal form
Anpartsselskab
NACE code
8621 · General medical practice activities
Founded
25. juni 1990
Share capital
DKK 200.000
Employees
3 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at eje og drive lægehuset Kerteminde samt anden dermed i forbindelse stående virksomhed
Address
Vestre Stationsvej 25
Phone
+4558588230
Email
odense@lea.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.100 | 1.384 | 1.322 | 1.453 | 1.610 | 1.803 | 1.768 | 1.846 | 1.823 | 1.801 | 1.306 | 1.498 | 1.678 | 1.162 |
| Staff expenses | -737 | -796 | -746 | -764 | -839 | -835 | -819 | -721 | -799 | -942 | -790 | -829 | -792 | -830 |
| EBITDA | 1.009 | 694 | 518 | 685 | 1.047 | 1.281 | 1.199 | 1.250 | 295 | 936 | 356 | 747 | 1.104 | 731 |
| Depreciation & amort. | -5 | -5 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1.003 | 689 | 518 | 685 | 1.047 | 1.281 | 1.199 | 1.250 | 295 | 936 | 356 | 747 | 1.104 | 731 |
| Net financials | -435 | -267 | -256 | -246 | -239 | -266 | -215 | -242 | -108 | -102 | -95 | -82 | -76 | -84 |
| Profit before tax | 569 | 422 | 262 | 439 | 808 | 1.015 | 985 | 1.008 | 187 | 834 | 261 | 665 | 1.028 | 648 |
| Tax | 105 | 81 | 66 | 105 | 181 | 227 | 222 | 227 | 50 | 193 | 65 | 151 | 236 | 146 |
| Net profit | 464 | 342 | 197 | 334 | 627 | 788 | 762 | 781 | 136 | 641 | 196 | 514 | 792 | 502 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7.277 | 7.252 | 7.116 | 7.084 | 7.217 | 7.596 | 7.954 | 8.191 | 7.631 | 7.605 | 7.433 | 7.637 | 7.960 | 7.979 |
| Equity | 756 | 897 | 894 | 1.028 | 1.355 | 1.843 | 2.305 | 2.786 | 2.622 | 2.964 | 3.160 | 3.674 | 4.266 | 4.567 |
| Long-term debt | 6.155 | 5.858 | 5.657 | 5.397 | 5.128 | 4.890 | 4.601 | 4.399 | 4.102 | 3.801 | 3.498 | 3.193 | 2.884 | 2.574 |
| Short-term debt | 322 | 372 | 385 | 480 | 496 | 566 | 696 | 625 | 688 | 605 | 574 | 552 | 544 | 484 |
| Total debt | 6.477 | 6.229 | 6.043 | 5.877 | 5.625 | 5.456 | 5.297 | 5.024 | 4.790 | 4.406 | 4.072 | 3.745 | 3.428 | 3.058 |
EBITDA margin
62.9%
This company
15.8%
Market median
+298% vs market
20122025
Equity ratio
57.2%
This company
38.2%
Market median
+50% vs market
20122025
Return on equity
11.0%
This company
18.4%
Market median
+40% vs market
20122025
Net profit margin
43.2%
This company
8.1%
Market median
+433% vs market
20122025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20122025
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KL Founder | Founder | 1990 | — | — |
OK Founder | Founder | 1990 | — | — |
| Audit | 1990 | — | — | |
MT Founder | Founder | 1990 | — | — |
HV Management | Management | 1990 | — | — |
BF Founder | Founder | 1990 | — | — |
JE Management | Management | 2019 | — | — |
BR Founder | Founder | 1990 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20.0% | 20.0% | 2026 | |
| Individual | 20.0% | 20.0% | 2026 | |
| Individual | 20.0% | 20.0% | 2012 | |
| Individual | 20.0% | 20.0% | 2026 | |
| Individual | 10.0% | 10.0% | 2025 | |
| Individual | 10.0% | 10.0% | 2025 | |
| Individual | 20.0% | 20.0% | 2012 | |
| Individual | 15.0% | 15.0% | 2022 | |
| Individual | 20.0% | 20.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LÆGEHUSET KERTEMINDE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Lis Lomborg | Founder | 0 companies |
| Otto Krag Brysting | Founder | 0 companies |
| Statsaut. revisor P. Schak Larsen | Audit | 0 companies |
| Morten Toftager | Founder | 0 companies |
| Hans Vestergaard | Management | 0 companies |
| Birthe Furlie Larsen | Founder | 0 companies |
| Joachim Eduard Wengenroth | Management | 0 companies |
| Bjørn Richard Olsen | Founder | 0 companies |